Formulation: Advances in formulation development & manufacture for solid dosage, injectables, liquids & specialty dosage forms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Formulation
Oral tablets & capsules. Solutions, suspensions, injectables, as well as topical ointments, gels & solutions. Lyophilization (freeze drying), spray drying, hot-melt extrusion & nanocrystal technology.

Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research Exec to Retire; More...

November 19, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete response letter; Watson appoints VP of global operations; more...

Protect Your Scientific Intellectual Property: Proof of Lab Informatics Data Authenticity is Your Best Legal Defense

November 13, 2009

As a pharmaceutical or biotechnology organization, your formulas, treatments and clinical findings are the "lifeblood" of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing ownership, revenue and consequently your business if you can't prove time-of-creation and authenticity. Learn how you can implement simple, cost-effective, and automated controls to protect your scientific intellectual property.

Choosing the best construction material for powder processing equipment

November 13, 2009

Selecting the best material of construction is a crucial part of the plant design process, the aim being to balance performance and cost to best advantage. For powder processors, choosing a material that eases flow can pay dividends throughout the lifetime of the plant, but there is limited data on which to base this decision. A recent study by Freeman Technology highlights the role of the FT4 universal powder tester for such studies and provides some valuable comparative data for a wide range of commercially available materials and finishes.

Week of Nov. 9, 2009: Merck and Schering-Plough Begin Combined Operations; UCB Appoints VP; More...

November 12, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: 3M forms agreement with VaxInnate; TRIN Pharma appoints CEO; More...

AAPS Announces Annual Awards, Names 2009 Fellows

November 12, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology

The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week.

USP Revises Excipient Standards to Limit Contamination

November 5, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention (USP) revised its standards for propylene glycol and sorbitol solution

Week of Nov. 2, 2009: Eli Lilly Opens Biotech Center; Johnson & Johnson Announces Restructuring; PPD Acquires Chinese CRO; More...

November 5, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its business team.

Moisture-Activated Dry Granulation—Part I: A Guide to Excipient and Equipment Selection and Formulation Development

November 2, 2009

Pharmaceutical Technology

The authors explain a process for moisture-activated dry granulation in detail and provide guidance for the selection of excipients and equipment.

DIY Healthcare Reform

November 2, 2009

Pharmaceutical Technology

While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too.

ADVERTISEMENT

LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
25%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
59%
View Results
Jim MillerOutsourcing OutlookJim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
FindPharma Custom Search
Click here